Mallinckrodt

News

Ireland's Mallinckrodt closes spinout, rebrands as Keenova

Two new pharma companies - Keenova and Par Health - have now emerged from the merger of Mallinckrodt and Endo earlier this year.

News

Rumour confirmed as Mallinckrodt merges with Endo

Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.

News

Mallinckrodt sells Therakos unit on at a discount

Ireland-headquartered pharma group Mallinckrodt has agreed to divest its subsidiary Therakos to private equity firm CVC Capital Partners for $925 million, well below the $1.33 billion it pa

News

Mallinckrodt looking at a second bankruptcy filing

Mallinckrodt is facing the prospect of a second bankruptcy filing in the space of three years, as it struggles to get its business back on track and meet the requirement o

News

Mallinckrodt's long haul with terlipressin in US ends in app...

Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt.

News

Mallinckrodt tries again with kidney drug terlipressin

Manufacturing problems wreaked havoc with Mallinckrodt's first attempt to secure FDA approval of its treatment candidate terlipressin for hepatorenal syndrome (HRS), but the drugmaker is ha

Ireland's Mallinckrodt closes spinout, rebrands as Keenova

Rumour confirmed as Mallinckrodt merges with Endo

Mallinckrodt sells Therakos unit on at a discount

Mallinckrodt looking at a second bankruptcy filing

Mallinckrodt's long haul with terlipressin in US ends in app...

Mallinckrodt tries again with kidney drug terlipressin

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Mallinckrodt

Editor's Picks